Dr. Mohamed Hassani, Assistant Minister of Health and Population for Public Health Initiatives Projects, confirmed that adding rare diseases to the Medical Emergency Fund law will be one of the effective tools for treating these diseases and reducing the burden on the health system.
< /p>
This came during a dialogue session entitled “Access to Innovation”, which was organized by the Ministry of Health and Population, within the activities of the second edition of the World Conference on Population, Health and Human Development (PHDC24), which is held under the patronage of President Abdel Fattah El-Sisi, under the slogan “ Human Development: For a Sustainable Future.
The session addressed the burden of rare diseases on public health in Egypt, drawing a road map for cooperation protocols to provide innovative medicines, and accelerating access to innovative treatments through the public-private partnership model. In addition to discussing access to innovative treatment protocols for asthma, and reviewing the solutions and steps necessary to remove obstacles and challenges.
During the session, Dr. Muhammad Hassani reviewed how to choose rare diseases or any disease that can be included in public health funding. , explaining that since 2018, a specific approach has been followed to select effective medicines, based on studied treatment protocols, as well as effectiveness, and the economic value of using the medicine.
Hasani spoke: About the mechanisms of providing biological medicines, and the importance of finding special pathways To each country to provide biological medicines, which contributes to the development of local strategies for treatment, pointing in this regard to the “100 Million Health” initiative. And the tests it includes to detect genetic diseases, such as the initiative to screen those approaching marriage, and the initiative to screen for genetic diseases in newborns.
Dr. Hossam Hosni, Secretary-General of the Egyptian Health Council, stressed the importance of the health sector’s approach to strategies for preventing rare diseases. Instead of working only on providing biological medicines, he reviewed the challenges of providing health care to people with rare diseases and how to confront them through these strategies.
For his part, Dr. Hisham Badr, Vice President of the Unified Purchasing Authority, reviewed how to localize the pharmaceutical industries, especially Manufacturing biological medicines and vaccines, noting that the presence of about 174 pharmaceutical factories is clear evidence of the localization of the pharmaceutical industry in Egypt, pointing to the political trends to support and localize the local pharmaceutical industry, and the huge investment challenges facing the localization of this industry.
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “rosaelyoussef”“
